Best possible treatment and follow-up for patients with fatigue disorders
News | Date: 02.04.2025 |
Ministry of Health and Care Services
Minister of Health and Care Services Jan Christan Vestre met with four patient organizations on Tuesday, April 1, to discuss treatment options for fatigue disorders.
– Patient organizations are important partners for the health trusts and for the directorate when it comes to developing good health services. That is why I have invited them to discuss and hear their views on important studies on fatigue disorders, and the work ahead, says Minister of Health and Care Services Jan Christan Vestre.
The term fatigue disorders includes, among others, ME (myalgic encephalopathy), CFS (Chronic Fatigue Syndrome) and long covid. The meeting was attended by the patient associations Norwegian Covid Association, Norwegian ME Association, ME Parents and Recovery Norway. The Directorate of Health and the regional health authorities also participated. The Directorate of Health is responsible for the national guide and national patient course and the health authorities are responsible for reviewing the national competence service.
– We must ensure a good offer for patients with fatigue disorders. Several studies show that we need more knowledge and experience and a better adapted treatment offer, this also applies to conditions with long covid. We discussed this at the meeting with the patient organizations today, says Vestre.
The Norwegian Directorate of Health, in collaboration with professionals and patient organizations, has investigated and assessed what needs to be in place to have a national patient course for long-term fatigue. Work is underway to revise the national guide for CFS/ME. In addition, an expert group has submitted a summary of a Nordic research collaboration on COVID-19 late effects.
– This is a complex topic with many different perspectives. We will summarize the various studies and viewpoints that emerged in today's meeting, and decide how this will be followed up further. The goal is to provide patients with fatigue disorders with the best possible treatment and follow-up, concludes Vestre.